healthi
adult
homo
sapien
frequent
circul
cell
respond
pyrophosphomonoest
alkylamin
togeth
refer
nonpeptid
antigen
npag
nitrogencontain
bisphosphon
seemingli
low
toxic
bisphosphon
pyrophosphomonoest
drug
vivo
may
allow
novel
approach
immunotherapi
viral
infect
exampl
drug
use
stimul
cell
releas
antivir
molecul
directli
suppress
viru
replic
without
destroy
virusrepl
cell
addit
solubl
molecul
releas
cell
could
boost
antivir
potenc
cytotox
lymphocyt
ctl
promot
antigen
present
rel
therapeut
valu
druginduc
direct
antivir
immunoregulatori
activ
may
depend
infect
viru
well
natur
protect
immun
respons
viral
infect
adapt
innat
immun
reaction
cooper
protect
host
whenev
possibl
erad
control
infect
earli
synthesi
solubl
factor
cytokin
chemokin
influenc
substanti
subsequ
immun
respons
may
therefor
affect
cours
infect
one
import
effector
natur
immun
lymphocyt
display
broad
antivir
activ
differ
virus
retrovirus
flavivirus
paramyxovirus
orthomyxovirus
picornavirus
coronavirus
rhabdovirus
arenavirus
herpesvirus
hepadnavirus
orthopoxvirus
review
broad
antivir
activ
cell
like
play
crucial
defens
role
especi
consid
rel
larg
number
eg
approxim
one
everi
adult
human
peripher
blood
lymphocyt
lymphocyt
respond
quickli
typic
antigen
process
requir
potent
major
histocompat
complex
mhc
unrestrict
activ
cell
releas
solubl
antivir
factor
mani
natur
ligand
recogn
human
cell
known
probabl
import
repres
group
intermedi
isoprenoid
biosynthesi
eg
isopentenylpyrophosph
first
isol
mycobacteria
natur
synthet
phospholigand
alkylamin
aminobiphosphon
also
stimul
cell
structurefunct
studi
ligand
suggest
molecul
could
readili
dock
put
bind
site
tcr
function
matur
cell
express
cellsurfac
inhibitori
receptor
mhc
class
molecul
inmr
may
control
tcrmediat
reactiv
antivir
respons
phosphostim
phosphobromohydrin
first
drug
design
stimul
select
cell
current
new
drug
phase
iphas
ii
clinic
trial
cancer
patient
nitrogencontain
bisphosphon
nbp
use
prevent
bone
deminer
patient
osteoporosi
multipl
myeloma
certain
metastat
cancer
eg
breast
prostat
recent
nbp
shown
induc
activ
cell
accompani
augment
cytotox
activ
b
product
c
dna
synthet
respons
cell
unexpect
activ
nbp
open
new
possibl
therapeut
usag
drug
mechan
nbp
action
appear
includ
inhibit
farnesyl
pyrophosph
synthas
activ
one
key
enzym
mevalon
pathway
farnesyl
pyrophosph
synthas
catalyz
sequenti
headtotail
condens
two
molecul
isopentenyl
pyrophosph
dimethylallyl
pyrophosph
lead
accumul
isopentenyl
pyrophosph
essenti
metabolit
directli
recogn
cell
interestingli
mevalon
pathway
critic
protein
prenyl
may
import
viral
assembl
fig
hepatoma
cell
expos
lovastatin
inhibitor
hmgcoa
reductas
enzym
catalyz
convers
hmgcoa
mevalon
hepatit
c
viru
hcv
rna
replic
impair
due
dissolut
hcv
replic
complex
lovastatin
treatment
also
block
respiratori
syncyti
viru
rsv
replic
celltocel
fusion
vivo
vitro
inhibit
isoprenyl
cellular
protein
rhoa
similarli
inhibitor
protein
prenyl
block
product
hepat
delta
viru
hdv
particl
vitro
dose
depend
manner
particular
inhibit
larg
delta
antigen
prenyl
mediat
interfer
assembl
hdv
virion
addit
increas
concentr
larg
delta
antigen
within
infect
cell
may
act
potent
tran
domin
inhibitor
hdv
replic
block
mevalon
pathway
nbp
also
result
decreas
synthesi
cholesterol
report
cholesterol
critic
hiv
passag
cell
membran
abil
nef
protein
increas
viral
infect
depend
cholesterol
specif
nef
involv
transport
newli
synthes
cholesterol
site
viral
bud
promot
incorpor
cholesterol
viral
particl
data
suggest
effici
cholesterol
synthesi
hivinfect
cell
import
product
infecti
virion
altogeth
result
open
new
possibl
use
inhibitor
mevalon
pathway
doubleedg
swordsthat
antivir
interf
virion
product
well
stimul
cell
cytotox
antivir
effect
immun
respons
viral
infect
compris
cytolyt
ie
cytotox
virusinfect
cell
noncytolyt
activ
cell
innat
noncytolyt
activ
encompass
product
releas
sever
solubl
molecul
shown
fig
peripher
blood
mononuclear
cell
pbmc
stimul
isopentenyl
pyrophosph
ipp
classic
nonpeptid
antigen
cell
releas
array
cytokin
eg
gmcsf
tpo
osm
chemokin
eg
rant
mdc
gro
known
antivir
andor
immunomodulatori
properti
stimul
sharp
contrast
mani
tcrexpress
lymphoid
cell
singl
lymphocyt
produc
one
solubl
antiviralimmunoregulatori
factor
fig
innat
respons
follow
humor
cellular
adapt
immun
respons
influenc
mani
solubl
molecul
addit
noncytolyt
antivir
molecul
continu
suppress
infecti
process
vital
organ
without
destroy
import
cell
also
boost
antivir
potenc
classic
cytotox
lymphocyt
ctl
main
factor
known
antivir
activ
releas
cell
key
molecul
recruit
activ
killer
cell
nk
cell
macrophag
trigger
intracellular
pathway
suppress
viral
replic
without
direct
cytolyt
effect
host
cell
vitro
noncytolyt
antivir
activ
interferon
demonstr
infect
hcv
hepat
b
viru
hbv
herpesvirus
orthopoxvirus
picornavirus
retrovirus
influenza
type
virus
review
hepat
btransgen
mice
releas
cell
abl
diminish
hbv
gene
express
replic
activ
hepatocyt
clear
viru
noncytolyt
pathway
acut
phase
hcv
infect
abil
cell
produc
associ
viru
clearanc
recent
shown
peptidestimul
cell
releas
reduc
hcv
rna
replic
activ
gener
chimpanze
pan
troglodyt
appear
ctl
better
correl
protect
hcv
antibodi
respons
compat
idea
product
tlymphocyt
may
contribut
resolut
infect
despit
potent
interferon
effect
major
fig
contrast
lymphocyt
cell
substanti
proport
activ
lymphocyt
produc
multipl
cytokin
human
pbmc
incub
h
cultur
medium
sodium
pamidron
intracellular
presenc
assess
flow
cytometri
last
h
incub
brefeldin
gml
present
block
cytokin
releas
cell
polyclon
stimul
concanavalin
shown
gener
similar
patternthat
larg
number
doubl
produc
contrast
predomin
singl
produc
except
substanti
larger
amount
cell
cytokin
product
pamidronatestimul
cultur
inhibit
mab
suggest
releas
pamidronatestimul
cell
may
import
factor
induct
cytokin
synthesi
test
cell
pool
patient
becom
persist
infect
hcv
chronic
infect
associ
drastic
impair
product
cell
hepat
expans
hcvspecif
lymphocyt
regulatori
phenotyp
thu
induct
product
lymphocyt
could
repres
new
strategi
inhibit
viral
replic
support
immun
respons
produc
activ
cell
either
stimulatori
inhibitori
effect
hiv
infect
also
shown
cytomegaloviru
cmv
infect
reduc
marrow
stromal
cell
either
secret
treat
exogen
stimul
cell
also
produc
potent
lymphoid
cell
growth
factor
affect
blymphocyt
tlymphocyt
hybridoma
cell
may
influenc
cytotox
cell
combin
factor
product
skin
fibroblast
support
replic
dengu
viru
flavivirus
vivo
may
import
factor
control
flaviviru
infect
moreov
shown
strengthen
retino
acidmedi
suppress
replic
macrophag
granulocytemacrophag
colonystimul
factor
gmcsf
produc
activ
cell
potent
speciesspecif
stimul
precursor
granulocyt
macrophag
eosinophil
antivir
effect
gmcsf
report
dengu
infect
gmcsf
boost
antivir
humor
immun
influenza
simian
immunodefici
viru
siv
increas
humor
cellular
immun
respons
herp
simplex
improv
protect
epsteinbarr
viru
ebv
induc
lymphoprolif
disord
also
thrombopoietin
stimul
prolifer
matur
megakaryocyt
oncostatin
growth
regul
cytokin
secret
activ
cell
effect
viral
replic
remain
unclear
chemokin
superfamili
proinflammatori
cytokin
releas
mani
activ
cell
chemokin
act
primarili
chemoattract
activ
specif
type
leukocyt
chemokin
rant
influenc
directli
rate
hiv
replic
stromalderiv
factor
block
entri
celltrop
isol
identifi
ligand
lestrfusin
rant
inhibit
celltrop
isol
macrophag
chemotact
protein
mdc
macrophagederiv
chemokin
also
block
entri
antivir
factor
eg
caf
inhibit
transcript
postintegr
mode
action
make
caf
distinct
similar
importantli
antigenstimul
cell
produc
hivinhibitori
rant
block
coreceptordepend
eg
bal
coreceptordepend
eg
lai
viral
isol
howev
like
addit
molecularli
defin
antivir
activ
cell
contribut
observ
antivir
effect
antigenstimul
cell
rapidli
establish
chemotact
gradient
may
shape
host
inflammatori
respons
variou
pathogen
includ
hiv
activ
cell
ipp
induc
within
h
product
lymphotactin
macrophag
chemoattract
induct
unaffect
ipp
plu
releas
block
cell
also
express
mani
receptor
includ
downregul
activ
stimuli
activ
signal
cell
also
induc
product
macrophag
chemoattract
mdc
play
import
role
inflammatori
respons
blood
monocyt
tissu
macrophag
inhibit
replic
via
mdc
chemotact
monocyt
dendrit
cell
activ
lymphocyt
nk
cell
exhibit
activ
cumul
high
level
proinflammatori
cytokin
chemokin
antivir
properti
produc
activ
cell
may
influenc
progress
hiv
diseas
interest
ippinduc
molecul
includ
epitheli
neutrophil
activ
chemotact
activ
factor
neutrophil
human
gro
mgsa
promot
neutrophil
chemotaxi
degranul
molecul
cell
may
influenc
behavior
granulocytesthat
cell
like
releas
noncytolyt
antivir
factor
famili
antimicrobi
peptid
identifi
anim
includ
human
nonhuman
primat
plant
play
import
role
infect
inflamm
wound
repair
acquir
immun
base
disulfid
pair
characterist
six
cystein
residu
divid
mainli
releas
granulocyt
inhibit
hiv
infect
vitro
addit
antihiv
activ
interfer
replic
cmv
vesicular
stomat
viru
vsv
influenza
viru
express
cell
describ
studi
requir
explor
contribut
cell
product
action
defensin
viral
infect
anoth
proinflammatori
factor
releas
activ
cell
potent
lymphoid
factor
unlik
molecul
describ
cytotox
effect
wide
rang
target
cell
benefici
effect
cellular
immun
vsv
cmv
vaccinia
viru
note
shown
enhanc
replic
chronic
infect
promonocyt
tlymphoid
cell
line
activ
nuclear
factor
nfb
stimul
long
termin
repeat
ltr
proviru
contrast
import
enhanc
product
macrophag
inhibit
growth
primari
macrophag
protect
role
activ
cell
virus
enhanc
express
cell
mediat
increas
suscept
infect
hiv
siv
strain
therefor
role
hiv
infect
somewhat
intric
studi
need
clarifi
effect
novel
synthet
drug
nbp
phosphostim
activ
cell
develop
recent
well
effect
vivo
protocol
molecul
abl
activ
cell
also
inhibit
protein
prenyl
cholesterol
biosynthesi
may
requir
viral
assembl
thu
nbpsphosphostimbas
therapeut
strategi
consid
enhanc
current
inadequ
armament
fight
emerg
reemerg
virus
